|

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

RECRUITINGSponsored by Fu Jen Catholic University
Actively Recruiting
SponsorFu Jen Catholic University
Started2025-06-10
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07012759

Summary

This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need.
* Signed informed consent.

Exclusion Criteria:

* Patients under the age of 18.
* Patients with malignancies other than lung adenocarcinoma.

Conditions5

BiomarkersCancerLung AdenocarcinomaLung CancerPleural Effusion

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.